Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Cashin

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Gastrointestinal Oncology|May 10, 2021
Hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases: lessons learned from PRODIGE 7Peter Cashin, Paul H Sugarbaker
Pleura and Peritoneum|July 2, 2025
The impact of surgical staging in patients with colorectal peritoneal metastases scheduled for CRS-HIPECLana Ghanipour, Johan Wallin, Peter Cashin, et al.
Annals of Surgical Oncology|January 22, 2025
Patterns of Preoperative Tumor Markers Can Predict Resectability and Prognosis of Peritoneal Metastases: A Clustering AnalysisMalin Enblad, Peter Cashin, Lana Ghanipour, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 27, 2024
Omental metastases in patients with pseudomyxoma peritonei or colorectal peritoneal metastases - is routine omentectomy justified?Malin Enblad, Helgi Birgisson, Lana Ghanipour, et al.
Cancers|June 19, 2024
No Indication for Routine Resection of Surgical Scars during Cytoreductive Surgery and HIPECMalin Enblad, Lana Ghanipour, Peter Cashin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 18, 2020
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with or without early post-operative intraperitoneal chemotherapy for appendix neoplasms with peritoneal metastases: A propensity score analysisMikael L Soucisse, Oliver Fisher, Winston Liauw, et al.
Acta Haematologica|July 8, 2010
Acquired haemophilia A and Kaposi's sarcoma in an HIV-negative, HHV-8-positive patient: a discussion of mechanism and aetiologyPeter Cashin, Lars Göran Lundberg, Hans Hagberg, et al.
Plos One|December 28, 2021
Severe pulmonary complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are common and contribute to decreased overall survivalOlivia Sand, Mikael Andersson, Erebouni Arakelian, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 3, 2020
Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapyHelgi Birgisson, Malin Enblad, Sara Artursson, et al.
Clinical Colorectal Cancer|August 24, 2011
Appendiceal adenocarcinoids with peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy: a retrospective study of in vitro drug sensitivity and survivalPeter Cashin, Peter Nygren, Per Hellman, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Gastrointestinal Oncology|May 10, 2021
Hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases: lessons learned from PRODIGE 7Peter Cashin, Paul H Sugarbaker
Pleura and Peritoneum|July 2, 2025
The impact of surgical staging in patients with colorectal peritoneal metastases scheduled for CRS-HIPECLana Ghanipour, Johan Wallin, Peter Cashin, et al.
Annals of Surgical Oncology|January 22, 2025
Patterns of Preoperative Tumor Markers Can Predict Resectability and Prognosis of Peritoneal Metastases: A Clustering AnalysisMalin Enblad, Peter Cashin, Lana Ghanipour, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 27, 2024
Omental metastases in patients with pseudomyxoma peritonei or colorectal peritoneal metastases - is routine omentectomy justified?Malin Enblad, Helgi Birgisson, Lana Ghanipour, et al.
Cancers|June 19, 2024
No Indication for Routine Resection of Surgical Scars during Cytoreductive Surgery and HIPECMalin Enblad, Lana Ghanipour, Peter Cashin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 18, 2020
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with or without early post-operative intraperitoneal chemotherapy for appendix neoplasms with peritoneal metastases: A propensity score analysisMikael L Soucisse, Oliver Fisher, Winston Liauw, et al.
Acta Haematologica|July 8, 2010
Acquired haemophilia A and Kaposi's sarcoma in an HIV-negative, HHV-8-positive patient: a discussion of mechanism and aetiologyPeter Cashin, Lars Göran Lundberg, Hans Hagberg, et al.
Plos One|December 28, 2021
Severe pulmonary complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are common and contribute to decreased overall survivalOlivia Sand, Mikael Andersson, Erebouni Arakelian, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 3, 2020
Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapyHelgi Birgisson, Malin Enblad, Sara Artursson, et al.
Clinical Colorectal Cancer|August 24, 2011
Appendiceal adenocarcinoids with peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy: a retrospective study of in vitro drug sensitivity and survivalPeter Cashin, Peter Nygren, Per Hellman, et al.
Pageof 2